Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand-Reference-Cited by-同舟云学术

Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand

Published:2016-12 Issue: Volume:165 Page:100-107
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Hanif Muhammad,Moon Sally,Sullivan Matthew P.,Movassaghi Sanam,Kubanik Mario,Goldstone David C.,Söhnel Tilo,Jamieson Stephen M.F.,Hartinger Christian G.^ORCID

Funder

University of Auckland

Austrian Science Fund

India-New Zealand Education Council

Education New Zealand

India-New Zealand Research Institute

Royal Society of New Zealand

COST CM1105

National Institutes of Health and National Cancer Institute

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference52 articles.

1. Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA

2. NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

3. Challenges and Opportunities in the Development of Organometallic Anticancer Drugs

4. Development of anticancer agents: wizardry with osmium

5. Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding on the plecstatin anticancer agent class: exchange of the chlorido ligand for N-heterocyclic ligands;Australian Journal of Chemistry;2024-09-13

2. Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia;British Journal of Cancer;2024-07-05

3. A multifaceted approach towards organometallic anticancer agent development;Journal of Organometallic Chemistry;2024-05

4. Exploring the coordination chemistry of ruthenium complexes with lysozymes: structural and in-solution studies;Frontiers in Chemistry;2024-04-04

5. A Multifaceted Approach Towards Organometallic Anticancer Agent Development;2024